These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35370739)

  • 1. Bisphosphonates Targeting Ion Channels and Musculoskeletal Effects.
    Scala R; Maqoud F; Antonacci M; Dibenedetto JR; Perrone MG; Scilimati A; Castillo K; Latorre R; Conte D; Bendahhou S; Tricarico D
    Front Pharmacol; 2022; 13():837534. PubMed ID: 35370739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K
    Maqoud F; Scala R; Tragni V; Pierri CL; Perrone MG; Scilimati A; Tricarico D
    Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic Acid Modulation of TRPV1 Channel Currents in Osteoblast Cell Line and Native Rat and Mouse Bone Marrow-Derived Osteoblasts: Cell Proliferation and Mineralization Effect.
    Scala R; Maqoud F; Angelelli M; Latorre R; Perrone MG; Scilimati A; Tricarico D
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30754651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.
    Van Beek ER; Löwik CW; Papapoulos SE
    Bone; 2002 Jan; 30(1):64-70. PubMed ID: 11792566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ZD0947, a novel and potent ATP-sensitive K
    Mori K; Yamashita Y; Teramoto N
    Eur J Pharmacol; 2016 Nov; 791():773-779. PubMed ID: 27693800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary spasm and acute myocardial infarction due to a mutation (V734I) in the nucleotide binding domain 1 of ABCC9.
    Smith KJ; Chadburn AJ; Adomaviciene A; Minoretti P; Vignali L; Emanuele E; Tammaro P
    Int J Cardiol; 2013 Oct; 168(4):3506-13. PubMed ID: 23739550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylephrine preconditioning in embryonic heart H9c2 cells is mediated by up-regulation of SUR2B/Kir6.2: A first evidence for functional role of SUR2B in sarcolemmal KATP channels and cardioprotection.
    Jovanović S; Ballantyne T; Du Q; Blagojević M; Jovanović A
    Int J Biochem Cell Biol; 2016 Jan; 70():23-8. PubMed ID: 26556311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome.
    Scala R; Maqoud F; Zizzo N; Mele A; Camerino GM; Zito FA; Ranieri G; McClenaghan C; Harter TM; Nichols CG; Tricarico D
    Front Pharmacol; 2020; 11():604885. PubMed ID: 33329006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Am J Physiol; 1998 Jan; 274(1):C25-37. PubMed ID: 9458709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
    Russell RG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH
    Ann N Y Acad Sci; 2007 Nov; 1117():209-57. PubMed ID: 18056045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the chemistry and biological activity of the bisphosphonates.
    Ebetino FH; Hogan AM; Sun S; Tsoumpra MK; Duan X; Triffitt JT; Kwaasi AA; Dunford JE; Barnett BL; Oppermann U; Lundy MW; Boyde A; Kashemirov BA; McKenna CE; Russell RG
    Bone; 2011 Jul; 49(1):20-33. PubMed ID: 21497677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.
    Li CG; Cui WY; Wang H
    Acta Pharmacol Sin; 2016 Jan; 37(1):134-42. PubMed ID: 26725741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders.
    Maqoud F; Scala R; Hoxha M; Zappacosta B; Tricarico D
    CNS Neurol Disord Drug Targets; 2022; 21(2):130-149. PubMed ID: 33463481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiology of the aging bone and mechanisms of action of bisphosphonates.
    Dominguez LJ; Di Bella G; Belvedere M; Barbagallo M
    Biogerontology; 2011 Oct; 12(5):397-408. PubMed ID: 21695491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
    Russell RG; Watts NB; Ebetino FH; Rogers MJ
    Osteoporos Int; 2008 Jun; 19(6):733-59. PubMed ID: 18214569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mechanisms of Cantú syndrome-associated gain of function mutations in the ABCC9 (SUR2) subunit of the KATP channel.
    Cooper PE; Sala-Rabanal M; Lee SJ; Nichols CG
    J Gen Physiol; 2015 Dec; 146(6):527-40. PubMed ID: 26621776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.
    Wang Y; Panasiuk A; Grainger DW
    Mol Pharm; 2011 Aug; 8(4):1016-24. PubMed ID: 21186792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?
    Xu XL; Gou WL; Wang AY; Wang Y; Guo QY; Lu Q; Lu SB; Peng J
    J Transl Med; 2013 Dec; 11():303. PubMed ID: 24330728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of bisphosphonates to target bone cancer metastasis: an overview.
    Singh T; Kaur V; Kumar M; Kaur P; Murthy RS; Rawal RK
    J Drug Target; 2015 Jan; 23(1):1-15. PubMed ID: 25203856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.